AI study ‘exciting first step’ toward improving post-treatment surveillance of lung cancer patients
Asthma drug can block crucial SARS-CoV-2 protein
25 April 2022Link between Epstein-Barr virus and multiple sclerosis is a crucial discovery for people living with MS
25 April 2022AI study ‘exciting first step’ toward improving post-treatment surveillance of lung cancer patients
Artificial intelligence (AI) could help guide the post-treatment surveillance of non-small cell lung cancer (NSCLC) patients and improve outcomes as a result, according to a study led by researchers from The Royal Marsden NHS Foundation Trust in collaboration with The Institute of Cancer Research, London, and Imperial College London.
